|
|
|
09182
|
|
|
P.I.:
|
Ryotaro Nakamura, MD
|
(Cooperative Group)
|
|
Title:
|
BMT CTN 0802: A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD
|
| | |
|
|
09137
|
|
|
P.I.:
|
Ryotaro Nakamura, MD
|
(Institutional)
|
|
Title:
|
Detection and Functional Analysis of T-Cell Immune Responses to Lymphoma Antigens, PRAME and ZBTB7A (Pokemon), in Patients with Non-Hodgkin Lymphoma
|
|
|
07036
|
|
|
P.I.:
|
Ryotaro Nakamura, MD
|
(Institutional)
|
|
Title:
|
Evaluation of Immune Responses Against Male-Specific Minor Histocompatibility Antigens (H-Y mHAg) in Recipients and Donors of Allogeneic Hematopoietic Stem Cell Transplantation
|
|
|
06110
|
|
|
P.I.:
|
Ryotaro Nakamura, MD
|
(Cooperative Group)
|
|
Title:
|
BMT CTN 0402: A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus with Tacrolimus/Methotrexate as Graft-Versus-Host-Disease (GVHD)Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation
|
| | |
|
|
03131
|
|
|
P.I.:
|
Ryotaro Nakamura, MD
|
(NCI Approved External Peer Review)
|
|
Title:
|
A Phase I Study of De-Immunized DI-Leu16-IL2 Immunocytokine in Patients with B-Cell Non-Hodgkin’s Lymphoma
|
| | |
|